INTRODUCTION AND OBJECTIVES: Adequate antioxidant response is essential for tissue homeostasis and function. However, systems responsible for antioxidant response are down-regulated in some pathological situations and aging. This is the case for Nrf2 that orchestrates cellular response to oxidative stress. The aim was to evaluate pharmacological activation of Nrf2 on the impairment of endothelial relaxation and reactive oxygen species-induced responses in corpus cavernosum (CC) from aged rats and in CC and penile arteries from patients with erectile dysfunction (ED).
METHODS: Endothelium-dependent relaxations to carbachol and responses to H2O2 were evaluated in CC from 3-months (young) and 20-months (aged) old rats in the absence or the presence of the Nrf2-activators, sulforaphane (10 microM) and oltipraz (30 microM). Upregulation of Nrf2 was assessed by ELISA. The effects of these Nrf2-activators were also evaluated on endothelial relaxation and H2O2-induced responses in human corpus cavernosum (HCC) and penile resistance arteries (HPRA) obtained from patients undergoing penile prosthesis implantation.
RESULTS: Aged rats CC displayed ED and impaired endothelium-dependent and H2O2-induced relaxation. Ex vivo exposure to either sulforaphane or oltipraz improved endothelial and H2O2-induced relaxation of CC from aged rats. HCC and HPRA were obtained from 19 patients (age: 60.7þ/-2.0 years, hypertension: 8, dyslipidemia: 7, diabetes: 6, CVD: 4, obesity: 2). Treatment with sulforaphane improved endothelium-dependent (pD2 for acetylcholine: 5.18þ/-0.28 vs 6.34þ/-0.37*) as well as neurogenic relaxation (Emax: 45.7þ/-6.4% vs 60.9þ/-3.0%*) in HCC. Sulforaphane also improved endothelial (pD2 for acetylcholine: 5.82þ/-0.38 vs 7.21þ/-0.32*) and H2O2-induced vasodilation in HPRA (pD2 for H2O2: 4.13þ/-0.13 vs 5.07þ/-0.17*). Positive effects of Nrf2-activation were confirmed by the improvement of endothelial vasodilation driven by oltipraz in HPRA.
CONCLUSIONS: Pharmacological activation of Nrf2 improves cavernosal function in aged animals with ED. These effects were confirmed in human tissue, including penile arteries, from patients with ED, suggesting that Nrf2 activation could be a reasonable target for the management of ED. (CN) , improve erectile function, promote CN regeneration, and suppress apoptosis in a rat CN injury model. We examine the hypothesis that suppression of apoptosis and penile morphology changes after CN crush will be maximized with optimization of SHH delivery to both the penis and CN via PA hydrogels. Optimization of delivery conditions is essential for clinical translation to prostatectomy patients.
METHODS: The study was divided into 3 parts: 1. Optimization of SHH protein concentration delivered to the penis at the time of CN crush, 2. Maintain elevated SHH protein longer after CN crush with 2 SHH PA injections, 3. Examine additive effects with SHH delivery to both penis and CN at the time of CN crush. Bilateral CN crush was performed on Sprague Dawley rats (n¼67) and SHH or mouse serum albumin (MSA, control) protein was delivered by PA injected into the corpora cavernosa. Rats were sacrificed after 4 and 9 days. 2X SHH protein was also assayed at 4 days. A second SHH PA injection at 5 days occurred prior to sacrifice at 9 days. Additional rats had SHH or MSA delivered to both the penis and CN by PA. TUNEL, trichrome stain and western analysis were performed.
RESULTS: Apoptosis increased 54% 4 days after injury (p¼0.0001). SHH PA suppressed apoptosis 27% at 4 days after CN injury (p¼0.005). 2X SHH protein suppressed apoptosis 29% (p¼0.003). Apoptosis increased 21% at 9 days after injury (p¼0.014). Two SHH PA injections decreased apoptosis 22% at 9 days (p¼0.021), while one SHH PA injection was indistinguishable from controls (p¼0.830). SHH delivery to penis and CN decreased apoptosis 27% (p¼0.0001).
CONCLUSIONS: Apoptosis suppression was similar in CN resection and crush models in response to SHH treatment. One SHH PA injection suppressed apoptosis until protein was depleted. Increasing the duration of SHH treatment, by a second SHH PA injection, suppressed apoptosis longer. Delivery of SHH to both penis and CN had beneficial effects on CN regeneration and apoptosis suppression. Optimization of SHH PA delivery is essential for translation to prostatectomy patients to prevent ED.
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MP45-07 SONIC HEDGEHOG PROMOTES CAVERNOUS NERVE REGENERATION BY INDUCING SPROUTING OF NEURONS IN THE PELVIC GANGLIA AND CAVERNOUS NERVE
Ryan Dobbs*, Shawn Choe, Gail Prins, Chicago, IL; Daniel Harrington, Houston, TX; Samuel Stupp, Chicago, IL; Kevin McVary, Springfield, IL; Carol Podlasek, Chicago, IL INTRODUCTION AND OBJECTIVES: Sonic hedgehog (SHH) protein delivered by nanoparticle based peptide amphiphile (PA) nanofiber hydrogel to the cavernous nerve at the time of crush injury (prostatectomy model), is neuroprotective, promotes cavernous nerve (CN) regeneration, and return of erectile function, in a rat model. Little is known about the mechanism of how SHH promotes CN regeneration. We hypothesize that SHH promotes sprouting of pelvic ganglia and CN neurons that innervate the penis, in order to enhance regeneration. We examine this hypothesis in an in vitro organ culture model.
METHODS: The caudal portion of the pelvic ganglia and CN were dissected from adult Sprague Dawley rats (n¼47) and were grown Vol. 197, No. 4S, Supplement, Sunday, May 14, 2017 THE JOURNAL OF UROLOGY â e613
